Eva Muehlhofer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Venous Thromboembolism

Antiplatelet Therapy

Cardiovascular Events

Top Venues

Journal of thrombosis and haemostasis : JTH

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation 149 (8) (2024)
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation 149 (8) (2024)
Justin T Morrison, Mario Enrico Canonico, Sonia S Anand, Manesh R Patel, Eike Sebastian Debus, Mark R Nehler, Connie N Hess, Judith Hsia, Warren H Capell, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD. Circulation 149 (19) (2024)
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation 149 (8) (2024)
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation 149 (8) (2024)
Jennifer A Rymer, Sonia S Anand, Eike Sebastian Debus, Lloyd P Haskell, Connie N Hess, W Schuyler Jones, Eva Muehlhofer, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca, Manesh R Patel
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD. Circulation (2023)
Connie N Hess, Iris Baumgartner, Sonia S Anand, Mark R Nehler, Manesh R Patel, Eike Sebastian Debus, Michael Szarek, Warren Capell, Eva Muehlhofer, Scott D Berkowitz, Lloyd P Haskell, Rupert M Bauersachs, Marc P Bonaca, Judith Hsia
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD. Journal of the American Heart Association 11 (12) (2022)
Scott D Berkowitz, Rupert M Bauersachs, Michael Szarek, Mark R Nehler, Eike Sebastian Debus, Manesh R Patel, Sonia S Anand, Warren H Capell, Connie N Hess, Judith Hsia, Nicholas J Leeper, David De Padua Brasil, Lajos Mátyás, Rafael Diaz, Marianne Brodmann, Eva Muehlhofer, Lloyd P Haskell, Marc P Bonaca
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Nana Pogosova, Jacqueline Bosch, Deepak L Bhatt, Keith A A Fox, Stuart J Connolly, Marco Alings, Peter Verhamme, Eva Muehlhofer, Olga Shestakovska, Salim Yusuf, John William Eikelboom
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis. Circulation 145 (25) (2022)